About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Profile
Schools
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Scientometrics
Avg Impact Factor
h-index
g-index
★★
Articles
★★★
Articles
exaly
›
Institutions
›
George Institute for Global Health
›
Top Articles
George Institute for Global Health
United Kingdom
(georgeinstitute.org.uk)
5.6K
(top 5%)
articles
174.6K
(top 4%)
citations
1,168
(top 5%)
★★
articles
148
(top 2%)
★★★
articles
3.6
(top 8%)
Avg IF
169
(top 3%)
H-Index
295
(top 3%)
G-Index
1,032
journals
Most Cited Articles of George Institute for Global Health in 2021
Title
Journal
Year
Citations
The Lancet Global Health Commission on Global Eye Health: vision beyond 2020
The Lancet Global Health
2021
131
Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
BMJ, The
2021
94
Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial
Lancet Diabetes and Endocrinology,the
2021
91
Diazepam monotherapy for epilepsy
The Cochrane Library
2021
78
Chronic kidney disease
Lancet, The
2021
73
Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction: Results of DAPA-HF
Circulation
2021
69
Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial
JAMA - Journal of the American Medical Association
2021
46
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
Kidney International
2021
46
The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Kidney International
2021
42
Prediabetes and the risk of heart failure: A meta-analysis
Diabetes, Obesity and Metabolism
2021
40
Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial
Lancet Diabetes and Endocrinology,the
2021
38
Effect of Dapagliflozin on Clinical Outcomes in Patients With Chronic Kidney Disease, With and Without Cardiovascular Disease
Circulation
2021
36
Asthma and risk of infection, hospitalization, ICU admission and mortality from COVID-19: Systematic review and meta-analysis
Journal of Asthma
2021
35
Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure: Results From the EMBRACE-HF Trial
Circulation
2021
35
A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy
Kidney International
2021
35
Obesity as a risk factor for COVID-19 mortality in women and men in the UK biobank: Comparisons with influenza/pneumonia and coronary heart disease
Diabetes, Obesity and Metabolism
2021
34
Characterization and implications of the initial estimated glomerular filtration rate 'dip' upon sodium-glucose cotransporter-2 inhibition with empagliflozin in the EMPA-REG OUTCOME trial
Kidney International
2021
33
Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses
Diabetologia
2021
32
Towards a multi-level framework of household food waste and consumer behaviour: Untangling spaghetti soup
Appetite
2021
28
The impact of the COVID-19 pandemic on the care and management of patients with acute cardiovascular disease: a systematic review
European Heart Journal Quality of Care & Clinical Outcomes
2021
27
SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation
American Journal of Kidney Diseases
2021
27
Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data
Lancet, The
2021
26
Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial
European Heart Journal
2021
25
A kidney perspective on the mechanism of action of sodium glucose co-transporter 2 inhibitors
Cell Metabolism
2021
25
An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis
Pharmacoeconomics
2021
25
site/software ©
exaly
; All materials licenced under
CC by-SA
.